EU AI Act Art 6
-
EC consults on high-risk AI systems in life sciences and healthcare
Many life sciences and healthcare companies develop or deploy AI-based medical devices and digital health solutions that may fall within the high-risk category.
-
Meeting the challenge of agentic AI and the EU AI Act
Agentic AI systems are designed to act autonomously, sense their environment, make decisions, and take actions without constant human oversight.